Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (201-210 of 494) with videos related to

Pageof 50
Sort By:
The American Journal of Pathology|January 1, 2014
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletionMaria C Tsourlakis, Philipp Weigand, Katharina Grupp, et al.
Cancer Research|December 3, 2004
Prognostic relevance of gene amplifications and coamplifications in breast cancerKhawla Al-Kuraya, Peter Schraml, Joachim Torhorst, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 2006
Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagusUta Reichelt, Peer Duesedau, Maria Ch Tsourlakis, et al.
Clinical Epigenetics|October 24, 2019
Random forest-based modelling to detect biomarkers for prostate cancer progressionReka Toth, Heiko Schiffmann, Claudia Hube-Magg, et al.
Translational Andrology and Urology|April 14, 2021
Mismatch repair deficiency occurs very rarely in seminomasDavid Dum, Stefan Steurer, Ronald Simon, et al.
Human Pathology|February 22, 2015
Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancersChristoph Burdelski, Ysé Barreau, Ronald Simon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lungTobias J Grob, Ivonne Kannengiesser, Maria C Tsourlakis, et al.
Translational Lung Cancer Research|December 10, 2025
High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancerBirgit Hantzsch-Kuhn, Nina Schraps, Martin Reck, et al.
Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncotarget|February 21, 2020
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypesFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
Pageof 50

Showing results (201-210 of 494) with videos related to

Sort By:
Pageof 50
The American Journal of Pathology|January 1, 2014
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletionMaria C Tsourlakis, Philipp Weigand, Katharina Grupp, et al.
Cancer Research|December 3, 2004
Prognostic relevance of gene amplifications and coamplifications in breast cancerKhawla Al-Kuraya, Peter Schraml, Joachim Torhorst, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 2006
Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagusUta Reichelt, Peer Duesedau, Maria Ch Tsourlakis, et al.
Clinical Epigenetics|October 24, 2019
Random forest-based modelling to detect biomarkers for prostate cancer progressionReka Toth, Heiko Schiffmann, Claudia Hube-Magg, et al.
Translational Andrology and Urology|April 14, 2021
Mismatch repair deficiency occurs very rarely in seminomasDavid Dum, Stefan Steurer, Ronald Simon, et al.
Human Pathology|February 22, 2015
Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancersChristoph Burdelski, Ysé Barreau, Ronald Simon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lungTobias J Grob, Ivonne Kannengiesser, Maria C Tsourlakis, et al.
Translational Lung Cancer Research|December 10, 2025
High GLUT1 protein expression is associated with unfavorable tumor features and poor prognosis in non-small cell lung cancerBirgit Hantzsch-Kuhn, Nina Schraps, Martin Reck, et al.
Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncotarget|February 21, 2020
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypesFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
Pageof 50